Literature DB >> 35040091

Genotype-phenotype correlations in alpha-sarcoglycanopathy: a systematic review.

Luke Carson1, Deborah Merrick2.   

Abstract

BACKGROUND: Mutations in the alpha-sarcoglycan gene cause limb-girdle muscular dystrophy 2D, an autosomal recessive muscle wasting disorder primarily affecting the muscles of the shoulder and pelvic girdles. To date, no previous study has collated all known mutations in alpha-sarcoglycan and mapped these to the associated phenotypes. AIMS: To examine for correlations between mutation locations, or mutation type, and the phenotype caused in all reported mutations in alpha-sarcoglycan.
METHODS: We present a systematic literature review examining correlations between mutation locations, or mutation type, and the phenotype caused in all reported cases of limb-girdle muscular dystrophy 2D.
RESULTS: From 134 unique genotypes collated, a strong prevalence of missense mutations (64% of all unique mutations) was found in this gene. Mutation hotspots were noted in exon three and the extracellular domain, with mutation densities varying significantly between both exons and protein domains (p ≤ 0.01). All compound heterozygous limb-girdle muscular dystrophy 2D patients with cardiac involvement contained at least one mutation in exon three, a novel finding. All non-sense mutations in alpha-sarcoglycan give a severe phenotype, as do genotypes involving a combination of exons four and five. This study confirms on a large, diverse cohort the extremely high prevalence of the c.229C > T mutation.
CONCLUSIONS: This study demonstrates the vast variation in disease severity seen between patients possessing the same mutation, highlighting the difficulty identifying genotype-phenotype correlations in this condition. Novel findings including the involvement of exon three in all compound heterozygous patients who suffered from cardiomyopathy, and the severity of mutations involving exons four and five may help to guide investigations and therapeutic decisions in an era of personalised medicine.
© 2021. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Alpha; Correlation; Dystrophy; Genotype; Muscular; Phenotype; Sarcoglycan

Year:  2022        PMID: 35040091     DOI: 10.1007/s11845-021-02855-1

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  21 in total

1.  Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy.

Authors:  B Eymard; N B Romero; F Leturcq; F Piccolo; A Carrié; M Jeanpierre; H Collin; N Deburgrave; K Azibi; M Chaouch; L Merlini; C Thémar-Noël; I Penisson; M Mayer; O Tanguy; K P Campbell; J C Kaplan; F M Tomé; M Fardeau
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

2.  epsilon-sarcoglycan replaces alpha-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex.

Authors:  V Straub; A J Ettinger; M Durbeej; D P Venzke; S Cutshall; J R Sanes; K P Campbell
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

3.  Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle.

Authors:  J M Ervasti; K Ohlendieck; S D Kahl; M G Gaver; K P Campbell
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

4.  Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin).

Authors:  S L Roberds; R D Anderson; O Ibraghimov-Beskrovnaya; K P Campbell
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

5.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

Authors:  B J Petrof; J B Shrager; H H Stedman; A M Kelly; H L Sweeney
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

6.  Human adhalin is alternatively spliced and the gene is located on chromosome 17q21.

Authors:  E M McNally; M Yoshida; Y Mizuno; E Ozawa; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

7.  Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12.

Authors:  L E Lim; F Duclos; O Broux; N Bourg; Y Sunada; V Allamand; J Meyer; I Richard; C Moomaw; C Slaughter
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

8.  Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy.

Authors:  S L Roberds; F Leturcq; V Allamand; F Piccolo; M Jeanpierre; R D Anderson; L E Lim; J C Lee; F M Tomé; N B Romero
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

9.  Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.

Authors:  L Politano; V Nigro; L Passamano; V Petretta; L I Comi; S Papparella; G Nigro; P F Rambaldi; P Raia; A Pini; M Mora; M A Giugliano; M G Esposito; G Nigro
Journal:  Neuromuscul Disord       Date:  2001-03       Impact factor: 4.296

10.  Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein.

Authors:  V Nigro; G Piluso; A Belsito; L Politano; A A Puca; S Papparella; E Rossi; G Viglietto; M G Esposito; C Abbondanza; N Medici; A M Molinari; G Nigro; G A Puca
Journal:  Hum Mol Genet       Date:  1996-08       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.